Superinduction of P-glycoprotein messenger RNA in vivo in the presence of transcriptional inhibitors

Journal of Experimental Therapeutics and Oncology

Volumn 3, Issue 1, 2003, Pages 14-26

  Lee, Chow H ^a   Ling, Victor ^b  

^a UNIVERSITY OF NORTHERN BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

mRNA half life; Normal tissues; P glycoprotein; Transcriptional inhibition

Indexed keywords

ALPHA AMANITIN; CYCLIN D1; DACTINOMYCIN; GLYCOPROTEIN P; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART; KIDNEY; LIVER; LIVER CARCINOGENESIS; LUNG; MALE; MULTIDRUG RESISTANCE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RIBONUCLEASE PROTECTION ASSAY; RNA STABILITY; SMALL INTESTINE; SPLEEN; TRANSCRIPTION REGULATION;

AMANITINS; ANIMALS; DACTINOMYCIN; HALF-LIFE; INJECTIONS, INTRAPERITONEAL; INTESTINE, SMALL; KIDNEY; LIVER; LUNG; MALE; MYOCARDIUM; NUCLEIC ACID SYNTHESIS INHIBITORS; P-GLYCOPROTEINS; RATS; RATS, INBRED F344; RNA, MESSENGER; SPLEEN; TRANSCRIPTION, GENETIC;

EID: 0037735299     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1359-4117.2003.01063.x     Document Type: Article

References (58)

1. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39: 361-398, 1999.
2. Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58: 137-171, 1989.
3. Gottesman MM, Pastan I. The multidrug transporter, a double-edged sword. Annu Rev Biochem 62: 385-427, 1993.
4. Silverman JA, Schrenk D. Hepatic canalicular membrane 4: expression of the multidrug resistance genes in the liver. FASEB J 11: 308-313, 1997.
5. Klein I, Sarkadi B, Varadi A. An inventory of the human ABC proteins. Biochim Biophys Acta 1461: 237-262, 1999.
6. Ling V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 40: S3-S8, 1997.
7. Schinkel AH. The physiological function of drug-transporting P-glycoproteins. Semin Cancer Biol 8: 161-170, 1997.
8. Schinkel AH. Pharmacological insights from P-glycoprotein knockout mice. Int J Clin Pharmacol Ther 36: 9-13, 1998.
9. Kohno K, Sato S-I, Takano H, Kato S, Matsuo K-I, Kuwano M. The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem Biophys Res Commun 165: 1415-1421, 1989.
10. Chin K-V, Chauhan SS, Pastan I, Gottesman MM. Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells. Cell Growth Differ 1: 361-365, 1990.
11. Fardel O, Lecureur V, Daval S, Corlu A, Guillouzo A. Up regulation of P-glycoprotein expression in rat liver cells by acute doxorubicin treatment. Eur J Biochem 246: 186-192, 1997.
12. Schrenk D, Michalke A, Gant TW, Brown PC, Silverman JA, Thorgeirsson SS. Multidrug resistance gene expression in rodents and rodent hepatocytes treated with mitoxantrone. Biochem Pharmacol 52: 1453-1460, 1996.
13. Furuya KN, Thottassery JV, Schuetz EG, Sharif M, Schuetz JD. Bromocriptine transcriptionally activates the multidrug resistance gene (pgp2/mdr1b) by a novel pathway. J Biol Chem 272: 11518-11525, 1997.
14. Gant TW, Silverman JA, Bisgaard HC, Burt RK, Marino PA, Thorgeirsson SS. Regulation of 2-acetylaminofluorene- and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P4501A gene family expression in primary hepatocyte cultures and rat liver. Mol Carcinog 4: 499-509, 1991.
15. Nakatsukasa H, Silverman JA, Gant TW, Evarts RP, Thorgeirsson SS. Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication. Hepatology 18: 1202-1207, 1993.
16. Uchiumi T, Kohno K, Tanimura H, Matsuo D, Sato S, Uchida Y, Kuwano M. Enhanced expression of the multidrug resistance gene in response to UV light irradiation. Cell Growth Differ 4: 147-157, 1993.
17. Chin K-V, Tanaka S, Darlington G, Pastan I, Gottesman MM. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J Biol Chem 265: 221-226, 1990.
18. Altuvia S, Stein WD, Goldenberg S, Kane SE, Pastan I, Gottesman MM. Targetted disruption of the mouse mdr1b gene reveals that steroid hormone enhance mdr gene expression. J Biol Chem 268: 27127-27132, 1993.
19. Zhao J-Y, Ikeguchi M, Eckersberg T, Kuo MT. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells. Endocrinology 133: 521-528, 1993.
20. Schuetz JD, Silverman JA, Thottassery JV, Furuya KN, Schuetz EG. Divergent regulation of the class II P-glycoprotein gene in primary cultures of hepatocytes versus H35 hepatoma by glucocorticoids. Cell Growth Differ 6: 1321-1332, 1995.
21. Schuetz JD, Schuetz EG. Extracellular matrix regulation of multidrug resistance in primary monolayer cultures of adult rat hepatocytes. Cell Growth Differ 4: 31-40, 1993.
22. Tatsuta T, Naito M, Mikami K, Tsuruo T. Enhanced expression by the brain matrix of P-glycoprotein in brain capillary endothelial cells. Cell Growth Differ 5: 1145-1152, 1994.
23. Silverman JA, Hill BA. Characterization of the basal and carcinogen regulatory elements of the rat mdr1b promoter. Mol Carcinog 13: 50-59, 1995.
24. Bargou RC, Jurchott K, Wagener C, Bergmann S, Metzner S, Bommert K, Mapara MY, Winzer K-J, etal. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med 3: 447-450, 1997.
25. Chin K-V, Ueda K, Pastan I, Gottesman MM. Modulation of the activity of the promoter of the human MDR1gene by Ras and p53. Science 255: 459-462, 1992.
26. Thottaserry JV, Sun D, Zambetti GP, Troutman A, Sukhatme VP, Schuetz EG, Schuetz JD. Sp1 and erg-1 have opposing effects on the regulation of the rat Pgp2/mdr1b gene. J Biol Chem 274: 3199-3206, 1999.
27. Zastawny RL, Salvino R, Chen J, Benchimol S, Ling V. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53. Oncogene 8: 1529-1535, 1993.
28. Fardel O, Loyer P, Lecureur V, Glaise D, Guillouzo A. Constitutive expression of functional P-glycoprotein in rat hepatoma cells. Eur J Biochem 219: 521-528, 1994.
29. Teeter LD, Estes M, Chan JY, Atassi H, Sell S, Becker FF, Kuo MT. Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis. Mol Carcinog 8: 67-73, 1993.
30. Nakatsukasa H, Evarts RP, Burt RK, Nagy P, Thorgeirsson SS. Cellular pattern of multidrug resistance gene expression during chemical hepatocarcinogenesis in the rat. Mol Carcinog 6: 190-198, 1992.
31. Marino PA, Gottesman MM, Pastan I. Regulation of the multidrug resistance gene in regenerating rat liver. Cell Growth Differ 1: 57-62, 1990.
32. Croop JM, Gros P, Housman D. The three-mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol 9:1346-1350, 1989.
33. Lee CH, Bradley G, Zhang J-T, Ling V. Differential expression of P-glycoprotein genes in primary rat hepatocyte culture. J Cell Physiol 157: 392-402, 1993.
34. Hill BA, Brown PC, Preisegger K-H, Silverman JA. Regulation of mdr1b gene expression in Fischer, Wistar and Sprague-Dawley rats in vivo and in vitro. Carcinogenesis 17: 451-457, 1996.
35. Lee CH, Bradley G, Ling V. Overexpression of the class II P-glycoprotein gene in primary rat hepatocyte culture: evidence for increased mRNA stability. Cell Growth Differ 6: 347-354, 1995.
36. Kren BT, Trembley JN, Steer CJ. Alterations in mRNA stability during rat liver regeneration. Am J Physiol 270: G763-G777, 1996.
37. Lee CH, Bradley G, Ling V. Increased P-glycoprotein messenger RNA stability in rat liver tumors in vivo. J Cell Physiol 177: 1-12, 1998.
38. Kuo MT, Julian J, Husain F, Song R, Carson DD. Regulation of multidrug resistance gene mdr1b/mdr1 expression in isolated mouse uterine epithelial cells. J Cell Physiol 164: 132-141, 1995.
39. Chianale J, Vollrath V, Wielandt AM, Miranda S, Gonzalez R, Fresno AM, Quitana C, Gonzalez S, et al. Differences between nuclear run-off and mRNA levels for multidrug resistance gene expression in the cephalocaudal axis of the mouse intestine. Biochim Biophys Acta 1264: 369-376, 1995.
40. Ross J. mRNA stability in mammalian cells. Microbiol Rev 59: 423-450, 1995.
41. Kren BT, Kumar NM, Wang S, Gilula NB, Steer CJ. Differential regulation of multiple gap junction transcripts and proteins during rat liver regeneration. J Cell Biol 123: 707-718, 1993.
42. Trembley JH, Kren BT, Steer CJ. Posttranscriptional regulation of cyclin B messenger RNA expression in the regenerating rat liver. Cell Growth Differ 5: 99-108, 1994.
43. Bradley G, Georges E, Ling V. Sex-dependent and independent expression of the P-glycoprotein isoforms in Chinese hamster. J Cell Physiol 145: 398-408, 1990.
44. Furuya KN, Gebhardt R, Schuetz EG, Schuetz JD. Isolation of rat pgp3 cDNA: evidence for gender and zonal regulation of expression in the liver. Biochim Biophys Acta 1219: 636-644, 1994.
45. Fonagy A, Swiderski C, Freeman JW. Nucleolar p120 is expressed as a delayed early response gene and is inducible by DNA-damaging agents. J Cell Physiol 164: 634-643, 1995.
46. White JE, Tsan M-F. Induction of pulmonary Mn superoxide dismutase mRNA by interleukin-1. Am J Physiol 266: L664-L671, 1994.
47. 1 cells: roles of protein and RNA synthesis. Mol Endocrinol 7: 1144-1150, 1993.
48. Gingalewski C, Wang K, Clemens MG, Maio AD. Posttranscriptional regulation of connexin32 expression in liver during acute inflammation. J Cell Physiol 166: 461-467, 1996.
49. Stacey KJ, Nagamine Y, Hume DA. RNA synthesis stabilizes urokinase mRNA in macrophages. FEBS Lett 356: 311-313, 1994.
50. Hamilton BJ, Nagy E, Malter JS, Arrick BA, Rigby WFC. Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. J Biol Chem 268: 8881-8887, 1993.
51. Katz DA, Theodorakis NG, Cleveland DW, Lindsten T, Thompson CB. AU-A, an RNA-binding activity distinct from hnRNP A1, is selective for AUUUA repeats and shuttles between the nucleus and the cytoplasm. Nucleic Acids Res 22: 238-246, 1994.
52. Pinol-Roma S, Dreyfuss G. Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm. Nature 355: 730-732, 1992.
53. Keene JD. Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc Natl Acad Sci USA 96: 5-7, 1999.
54. Ford LP, Watson J, Keene JD, Wilusz J. ELAV proteins stabilize deadenylated intermediates in novel in vitro mRNA deadenylation/degradation system. Genes Dev 13: 188-201, 1999.
55. Sidransky H, Murty CN, Verney E. Turnover of messenger RNA in transplantable hepatomas and host livers of rats. Cancer Res 38: 1645-1653, 1978.
56. Silverman RH, Jung DD, Nolan-Sorden NL, Diefienbach CW, Kedar VP, SenGupta DN. Purification and analysis of murine 2-5A-dependent RNase. J Biol Chem 263: 7336-7341, 1988.
57. Lee CH, Leeds P, Ross J. Purification and characterization of a polysome-associated endoribonuclease that degrades c-myc mRNA in vitro. J Biol Chem 273: 25261-25271, 1998.
58. Dompenciel RE, Garnepudi VR, Schoenberg DR. Purification and characterization of an estrogen-regulated Xenopus liver polysomal nuclease involved in the selective destabilization of albumin mRNA. J Biol Chem 270: 6108-6118, 1995.